Santen Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma analyst in JPMorgan. And it's my pleasure to introduce Shigeo Taniuchi, CEO of Santen, and welcome him to the conference.
The presentation will be followed directly by Q&A. (Operator Instructions) And for Q&A session, Satoshi Suzuki, Senior Corporate Officer, Head of Corporate Development Division will join.
With that, let me turn it over to Taniuchi-san. Please go ahead, Taniuchi-san.
(foreign language) Hello, everyone. Thank you very much for joining the session with us, Santen. So I'm Shigeo Taniuchi, CEO of Santen. I'm very happy to make a presentation today to you to update our strategy and also talk about our future outlook.
I think we are in a tight rope, Slide 1. So last year, 2020 was, of course, one of the most memorable and difficult year for global community.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |